Compare BSX & MCK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BSX | MCK |
|---|---|---|
| Founded | 1979 | 1833 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Other Pharmaceuticals |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 93.4B | 91.0B |
| IPO Year | 2010 | 1995 |
| Metric | BSX | MCK |
|---|---|---|
| Price | $48.80 | $766.69 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 22 | 14 |
| Target Price | $93.18 | ★ $952.92 |
| AVG Volume (30 Days) | ★ 20.8M | 985.5K |
| Earning Date | 04-22-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 0.40% |
| EPS Growth | ★ 55.20 | 49.22 |
| EPS | 0.90 | ★ 38.38 |
| Revenue | $9,076,000,000.00 | ★ $112,084,000,000.00 |
| Revenue This Year | $11.85 | $14.94 |
| Revenue Next Year | $10.16 | $8.21 |
| P/E Ratio | $54.16 | ★ $19.99 |
| Revenue Growth | ★ 12.49 | 3.11 |
| 52 Week Low | $47.17 | $637.00 |
| 52 Week High | $109.50 | $999.00 |
| Indicator | BSX | MCK |
|---|---|---|
| Relative Strength Index (RSI) | 31.95 | 48.82 |
| Support Level | N/A | $726.86 |
| Resistance Level | $58.35 | $779.31 |
| Average True Range (ATR) | 1.48 | 15.65 |
| MACD | -0.16 | 5.83 |
| Stochastic Oscillator | 13.35 | 71.66 |
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.
McKesson is one of three leading pharmaceutical wholesalers in the US engaged in sourcing and distributing branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with Cencora and Cardinal Health, the three account for over 90% of the US pharmaceutical wholesale industry. Outside the US market, McKesson engages in pharmaceutical wholesale and distribution in Canada. Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.